Is it Safe to Combine a Selective Serotonin Reuptake Inhibitor with Selegiline?

Gelenberg AJ . Sertraline-MAOI interaction. Biol Ther Psychiatry 1993; 16 (7).

Iacono R Toyama S Meltzer C . The use of selective serotonin reuptake inhibitors (SSRI) in the treatment of Parkinson's disease. Submitted to the 11th International Meeting on Parkinson's Disease. Rome, Italy: March 1994.

Tohgi H Abe T Takahashi S Takahashi J Hamato H . Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 1993; 150: 71–4.

Wesemann W Clement H Grote C . Functional studies on monoaminergic transmitter release in parkinsonism. Clin Neuropharmacol 1990; 13 (2):11–53.

Halliday GM Li Y-W Blumbey PC Neuropathology of immunohistochemically identified brain stem neurons in Parkinson's disease. Ann Neurol 1990; 27: 373–85.

Baldessarini RJ Cedarbaum JM Schleifer LS . In: Gilman AG Rall TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics 8th ed., New York: Pergamon Press, 1990: 384–435, 463–484.